| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €24,7853 | +3,97% | €1,50B | €435,70K | |
SGRY Surgery Partners, Inc. Common Stock | €11,7769 | +1,22% | €1,50B | €1,32M | |
GAB The Gabelli Equity Trust Inc. | €4,8227 | -0,18% | €1,50B | €1,09M | |
HURN Huron Consulting Group Inc. | €92,3895 | +2,36% | €1,49B | €87,36K | |
ENVX Enovix Corporation Common Stock | €7,1996 | +1,58% | €1,49B | €5,86M | |
PAYO Payoneer Global Inc. Common Stock | €4,4180 | +0,79% | €1,49B | €4,49M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12,8577 | +0,13% | €1,49B | €149,11K | |
STGW Stagwell Inc. Class A Common Stock | €5,7614 | +1,52% | €1,49B | €830,79K | |
CASH Pathward Financial, Inc. Common Stock | €68,0649 | +1,67% | €1,49B | €194,42K | |
SNDX Syndax Pharmaceuticals, Inc. | €15,5188 | -1,74% | €1,49B | €6,49M | |
STRA Strategic Education, Inc. Common Stock | €69,2835 | +1,77% | €1,49B | €192,21K | |
CAPR Capricor Therapeutics Inc | €24,0447 | +1,01% | €1,49B | €440,95K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15,3509 | -0,25% | €1,49B | €4,17K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,7852 | +10,38% | €1,49B | €7,13M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €23,1878 | +7,74% | €1,49B | €551,73K | |
